Search Results - "Pehlivanli, S"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Heart allograft endothelial cell dysfunction. Cause, course, and consequences by Weis, M, Pehlivanli, S, von Scheidt, W

    Published in Clinical research in cardiology (01-01-2000)
    “…Allograft coronary endothelial cells can serve as potent stimulators (antigen-presenting cells) as well as targets of allogeneic lymphocyte reactivity…”
    Get full text
    Journal Article
  2. 2

    Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure by Koglin, Jörg, Pehlivanli, Sinan, Schwaiblmair, Martin, Vogeser, Michael, Cremer, Peter, vonScheidt, Wolfgang

    “…Using a prospective study design, we assessed the value of brain natriuretic peptide (BNP) to identify patients with heart failure who have an increased risk…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function by PETRAKOPOULOU, Paraskevi, KIIBRICH, Marion, PEHLIVANLI, Sinan, MEISER, Bruno, REICHART, Bruno, VON SCHEIDT, Wolfgang, WEIS, Michael

    Published in Circulation (New York, N.Y.) (14-09-2004)
    “…Cardiac allograft vasculopathy (CAV) is initiated by allograft endothelial injury. We hypothesized that a major mechanism by which cytomegalovirus (CMV) could…”
    Get full text
    Journal Article
  5. 5

    Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation by Weis, Michael, Pehlivanli, Sinan, Meiser, Bruno M, von Scheidt, Wolfgang

    “…OBJECTIVES This study was designed to assess the association between 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibition, coronary endothelial…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pharmakologische Testung der Reversibilität eines erhöhten Lungengefäßwiderstandes vor Herztransplantation mit Prostaglandin I2 (Prostacyclin) by Trautnitz, M, Pehlivanli, S, Behr, J, Schwaiblmair, M, Überfuhr, P, Meiser, B, von, Scheidt W

    Published in Clinical research in cardiology (01-03-1999)
    “…Zusammenfassung Eine Erhöhung des pulmonalen Gefäßwiderstandes (PVR) oder des transpulmonalen Gradienten (TPG) ist ein wesentlicher Risikofaktor einer erhöhten…”
    Get full text
    Journal Article
  8. 8

    Vasodilator Response to Nifedipine in Human Coronary Arteries with Endothelial Dysfunction by Weis, Michael, Pehlivanli, Sinan, von Scheidt, Wolfgang

    Published in Journal of cardiovascular pharmacology (01-02-2002)
    “…The purpose of the current study was to evaluate nifedipine-induced epicardial and microvascular response in human coronary arteries with and without…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts by Wildhirt, S M, Weis, M, Schulze, C, Conrad, N, Pehlivanli, S, Rieder, G, Enders, G, von Scheidt, W, Reichart, B

    Published in Circulation (New York, N.Y.) (18-09-2001)
    “…Inducible nitric oxide synthase (iNOS) is expressed and is functionally active in the presence of transplant arteriosclerosis. However, the early involvement…”
    Get full text
    Journal Article
  11. 11

    Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients by WEIS, M, WILDHIRT, S. M, SCHULZE, C, PEHLIVANLI, S, FRAUNBERGER, P, MEISER, B. M, VON SCHEIDT, W

    Published in Transplantation (15-11-1999)
    “…Upon exposure to cytokines, endothelial cells may undergo profound alterations of vasomotor function. In this study, we characterized the relationship between…”
    Get full text
    Journal Article
  12. 12

    Coronary Vasomotor Dysfunction in the Cardiac Allograft: Impact of Different Immunosuppressive Regimens by Weis, Michael, Wildhirt, Stephen M, Schulze, Costas, Pehlivanli, Sinan, Rieder, Gabriele, Wolf, Wolf P, Wilbert-Lampen, Ute, Meiser, Bruno M, Enders, Georg, von Scheidt, Wolfgang

    Published in Journal of cardiovascular pharmacology (01-12-2000)
    “…Immunosuppression may have an important impact on early graft coronary endothelial injury. We investigated functional and morphologic coronary alterations,…”
    Get full text
    Journal Article
  13. 13

    Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation by STEINHAUFF, Silke, PEHLIVANLI, Sinan, BAKOVIC-ALT, Renata, MEISER, Bruno M, BECKER, Bernhard F, VON SCHEIDT, Wolfgang, WEIS, Michael

    Published in Transplantation (27-06-2004)
    “…We evaluated the potential of angiotensin-converting enzyme inhibition (ACEI) to modulate resting coronary vasomotor tone and endothelial dysfunction, and to…”
    Get full text
    Journal Article
  14. 14

    Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans by Wildhirt, Stephen M., Weis, Michael, Schulze, Costas, Conrad, Nicole, Pehlivanli, Sinan, Rieder, Gabi, Enders, Georg, von Scheidt, Wolfgang, Reichart, Bruno

    “…Objective: Coronary endothelial dysfunction may precede morphological changes in both the epicardial conduit and microvascular resistance vessels in heart…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16

    Pharmacological testing of the reversibility of increased pulmonary vascular resistance before heart transplantation with prostaglandin I2 (prostacyclin) by Trautnitz, M, Pehlivanli, S, Behr, J, Schwaiblmair, M, Uberfuhr, P, Meiser, B, von Scheidt, W

    Published in Zeitschrift für Kardiologie (01-02-1999)
    “…An increased pulmonary vascular resistance (PVR) or an increased transpulmonary gradient (TPG) is a risk factor for increased 3-day and 3-month mortality after…”
    Get more information
    Journal Article